Form 4 for TMDX TransMedics Group, Inc.
Accepted 2023-02-28 00:00:00 ET · period of report 2023-02-27 · accession 0000950170-23-005194 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-02-28 | 2023-02-27 | TMDX | Weill David | Dir | S - Sale+OE | $76.69 | -5,934 | 15.0K | -28% | -$455.1K |
| D | 2023-02-28 | 2023-02-27 | TMDX | Weill David | Dir | M - OptEx | $14.20 | +5,934 | 15.9K | +59% | +$84.3K |
| D | 2023-02-28 | 2023-02-27 | TMDX | Weill David | Dir | M - OptEx | $0.00 | -5,934 | 10.0K | -37% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-27 | S | D | 4,970 | $76.51 | 10,000 | D | — | — | (F2) The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $76.44 to $76.65, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. (F3) A Form 4 filed by the reporting person on November 14, 2022 inadvertently overstated the total number of shares held by the reporting person by 3,500 shares. The updated amounts reported here correct that error and reflect the reporting person's holdings. |
| 2 | Common | Common Stock | 2023-02-27 | S | D | 964 | $77.64 | 14,970 | D | — | — | (F1) The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $77.63 to $77.76, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. |
| 3 | Common | Common Stock | 2023-02-27 | M | A | 5,934 | $14.20 | 15,934 | D | — | — | |
| 4 | Derivative | Stock Option (Right to Buy) | 2023-02-27 | M | D | 5,934 | $0.00 | 10,000 | D | $14.20 · — to 2030-06-04 | 5,934 Common Stock | (F4) The option is fully vested. |